Filing Details
Matinas BioPharma Holdings, Inc. (AMEX:MTNB) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event.
8k filedAMEX:MTNB
Matinas BioPharma Holdings, Inc. (MTNB) Reports Material Event to SEC
Filing Details Matinas BioPharma Holdings, Inc. (AMEX:MTNB) filed a Form 8-K with the Securities and Exchange Commission on July 13, 2026, disclosing a material event. Market…
Market Context
Matinas BioPharma Holdings, Inc.'s stock currently trades at $0.48 with a market capitalization of $4.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Matinas BioPharma Holdings, Inc.'s stock.
All SEC filings for Matinas BioPharma Holdings, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View MTNB Stock Page
Frequently Asked Questions
Where can I read MTNB's SEC filings?
Browse all filings on our MTNB SEC filings page.
What types of SEC filings does Matinas BioPharma Holdings, Inc. file?
Public companies like Matinas BioPharma Holdings, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.